PUBLISHER: The Business Research Company | PRODUCT CODE: 1672442
PUBLISHER: The Business Research Company | PRODUCT CODE: 1672442
In vitro fertilization (IVF) is a process of fertilization where an egg is combined with sperm outside the body, in vitro ('in glass'). It is a sophisticated set of treatments intended to improve fertility, address genetic issues, and aid in child conception, primarily used to address infertility.
The main types of cycles in the IVF services market are fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. A fresh IVF cycle is completed using eggs and embryos that have never been frozen. In this process, eggs are extracted and fertilized in the laboratory with semen. Various service providers in the IVF services market include fertility clinics, hospitals, surgical centers, and clinical research institutes. These services find applications in sectors such as fertility clinics, hospitals, and other healthcare settings.
The IVF services market research report is one of a series of new reports from The Business Research Company that provides IVF services market statistics, including IVF services industry global market size, regional shares, competitors with an IVF services market share, detailed IVF services market segments, market trends and opportunities, and any further data you may need to thrive in the IVF services industry. This IVF services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The IVF services market size has grown rapidly in recent years. It will grow from $19.19 billion in 2024 to $21.3 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to increased increasing prevalence of pcos condition, increased cases of the premature ovarian failure, increasing rate of male infertility and insurance coverages to ivf procedures.
The IVF services market size is expected to see strong growth in the next few years. It will grow to $30.87 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising infertility rate, technological developments regarding fertility treatment, growing adoption of IVF services to aid in pregnancy, rising number of same sex couples, increase in number of fertility clinics, rise in disposable income and late parenthood. Major trends in the forecast period include providing mitochondrial replacement therapies to potentially overcome genetic disorders, adopting new technologies and provide and better solutions to people seeking for fertility treatments, offering PGT-A screening or testing program to potentially increase the chances of pregnancy, using artificial intelligence to reduce costs and time, implement blockchain based apps and adopting advanced technologies such as time-lapse microscopy for safe, uninterrupted and constant embryo observation.
The growth of the in vitro fertilization (IVF) services market is attributed to the increasing infertility rate. Infertility, defined as the inability to conceive within 12 months, affects around 12 to 13 couples in 100, according to the US Department of Health and Human Services. The Indian Journal of Community Medicine reports 15 to 20 million infertility cases in India alone. This rise in infertility has led individuals to turn to IVF services, contributing to the expansion of the market.
Government initiatives aimed at improving access to fertility treatments are expected to drive the growth of the IVF services market. Governments are undertaking specific actions, policies, or projects to address fertility-related issues. An example is the New South Wales Affordable IVF Program, where the New South Wales government committed $80 million from 2022-23 to 2025-26 to enhance access to affordable fertility treatments.
The application of platelet-rich plasma (PRP) is a recent technique increasingly employed to enhance the success rate of IVF, particularly in patients with recurrent implantation failures. PRP is utilized alongside IVF to improve egg quality, uterine lining thickness, and endometrial receptivity, primarily for cases of recurrent implantation failure. Studies show that women treated with PRP experience significant improvements in Follicle-Stimulating Hormone (FSH), Anti-Mullerian Hormone (AMH), and Antral Follicle Count (AFC), thereby aiding fertility.
Major companies in the IVF services sector are innovating by incorporating artificial intelligence (AI) into IVF treatments. The use of AI in IVF has the potential to transform fertility care by providing personalized, data-driven insights for clinicians and patients. For instance, Alife Health, a US-based healthcare company, launched new artificial intelligence software in October 2022 to advance IVF treatment outcomes, reduce costs, and support clinical decision-making during crucial stages of the IVF process.
In July 2023, BPEA EQT, a Hong Kong-based investment company, acquired a 60% stake in Indira IVF for approximately $657 million. This strategic move aims to strengthen Indira IVF's presence across India, explore expansion into neighboring markets, and enhance accessibility to fertility services and reproductive health for couples. Indira IVF is an India-based company specializing in providing IVF services.
Major companies operating in the IVF services market include Monash IVF Group, Virtus Health Limited, Chelsea and Westminster Hospital NHS Foundation Trust, Genea Limited, Boston IVF, IVF Spain, Morpheus Life Sciences Pvt. Ltd., Dunya IVF, Cardone Reproductive Medicine & Infertility LLC, Cloudnine Fertility, Sun Pharmaceuticals Industries Ltd., Cadila Healthcare Ltd., Trivector Origio Scientific, Lab IVF Asia Pte Ltd., LG Life Sciences, Bourn Hall Clinic, Southend Fertility, Indira IVF, Pearl Women Hospital & Yash IVF Center, Corion Fertility Clinic, Origin International Fertility Center, Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility and Healthcare, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, United Family Healthcare, The New Hope Fertility Center, Melinda Hospital, Bocah Indonesia, Daya Medika, Clinique de la Muette, Klinikum Stuttgart, DRK Kliniken Berlin, University Medical Center Freiburg, CREATE Fertility, The Centre for Reproductive & Genetic Health, The Bridge Centre, Next Generation Clinic, UNICA Clinic - Prague, Repromeda s.r.o., MD Medical Group, Univfy, Progyny, Advantia Health, Maven Clinic, Future Family, Instituto de Fertilidad Humana, The Colombian Center for Fertility and Sterility, NMC Health, Dubai Gynecology and Fertility Centre, New Life Medical Centre, Cairo Fertility Centre (Egypt), Queens Fertility Centre (Egypt), BPE Partners, Cleopatra Hospitals Group (CHG)
Western Europe was the largest region in the IVF services market in 2024. North America was the second largest region in global IVF services market share. The regions covered in the ivf services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the IVF services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The IVF services market includes revenues earned by entities by providing services such as conventional insemination services, and intracytoplasmic sperm injection services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
IVF Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ivf services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ivf services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ivf services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.